What is Codametrix?
Codametrix (CMX) operates as a wholly owned subsidiary of the Massachusetts General Physician Organization, one of the largest multi-specialty medical groups in the United States. The company is at the forefront of applying artificial intelligence to transform complex medical histories into automated reimbursement processes. By collaborating with partner health systems, Codametrix aims to significantly reduce administrative burdens and improve the efficiency of revenue capture, addressing a critical pain point in healthcare operations. Their AI-driven solution is designed to translate clinical data into actionable financial information, enhancing the financial health of healthcare providers.
How much funding has Codametrix raised?
Codametrix has raised a total of $95M across 2 funding rounds:
Series A
$55M
Series B
$40M
Series A (2023): $55M with participation from Frist Cressey Ventures, Yale Medicine, Martin Ventures, and SignalFire
Series B (2024): $40M led by SignalFire, Frist Cressey Ventures, and Transformation Capital
Key Investors in Codametrix
Frist Cressey Ventures
Frist Cressey Ventures is a venture capital firm dedicated to accelerating the growth of innovative companies that are transforming healthcare. They provide not only capital but also strategic support to help businesses thrive and implement systemic changes in the healthcare sector.
SignalFire
SignalFire is a venture capital firm designed as a technology company, focused on igniting growth for early-stage teams through data, AI, and expert support. They provide a range of services from portfolio support to strategic insights across various sectors including healthtech, fintech, and cybersecurity.
Transformation Capital
Founded in 2015 and headquartered in Boston, Massachusetts, Transformation Capital is a growth equity fund fully focused on innovative healthcare IT and services companies.
What's next for Codametrix?
The recent major strategic investment in Codametrix signals a pivotal moment for the company, likely enabling accelerated development and broader market penetration. With substantial backing, Codametrix is poised to further refine its AI capabilities and expand its reach across healthcare systems. The company's focus on automated reimbursements, powered by AI, positions it to capitalize on the growing demand for operational efficiency and financial optimization in healthcare. Future growth will likely involve deeper integration with electronic health record systems and strategic partnerships to enhance its value proposition in the competitive healthtech landscape.
See full Codametrix company page
